1st Quarter - Termination
SPLITOAK STRATEGIES LLC for ACCELERON PHARMA, INC
Client
Income
$30,000
Expenses
—
Terminated
Jan 1, 2022
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HR 5376, Build Back Better Act-impact on rare disease research
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | Special Assistant to the President for Legislative Affairs (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999) |
Health Issues HCR
HR 5376, Build Back Better Act-impact on rare disease research
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | Special Assistant to the President (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999) |
Taxation/Internal Revenue Code TAX
HR 5376, Build Back Better Act-importance of the Orphan Drug Tax Credit for rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | Special Assistant to the President (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.